Viewing Study NCT00551759


Ignite Creation Date: 2025-12-24 @ 2:30 PM
Ignite Modification Date: 2026-07-19 @ 11:32 AM
Study NCT ID: NCT00551759
Status: TERMINATED
Last Update Posted: 2023-07-03
First Post: 2007-10-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Sponsor: Eastern Cooperative Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the esophagus View
None chemoradiotherapy View
None oxaliplatin View
None cetuximab View
None docetaxel View